A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines

NCT01749423 · clinicaltrials.gov ↗

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Company decision due to enrollment challenges.

Conditions

Chronic Migraine, Headache

Interventions

BIOLOGICAL: OnabotulinumtoxinA

Sponsor

Allergan